Genetic Analysis AS (XSAT:GEAN)
Sweden · Delayed Price · Currency is SEK · Price in NOK 0.8000
+0.0250 (3.23%)
At close: Dec 3, 2025
Genetic Analysis AS Market Cap
Genetic Analysis AS has a market cap or net worth of 51.5 million as of December 4, 2025. Its market cap has increased by 66.71% in one year.
Market Cap
51.50M
Enterprise Value
41.54M
Revenue
20.45M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.80
Market Cap Chart
Since October 1, 2021, Genetic Analysis AS's market cap has decreased from 235.48M to 51.50M, a decrease of -78.13%. That is a compound annual growth rate of -30.52%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 3, 2025 | 51.50M | 110.55% |
| Dec 30, 2024 | 24.46M | -31.37% |
| Dec 29, 2023 | 35.64M | -34.69% |
| Dec 30, 2022 | 54.57M | -66.71% |
| Dec 30, 2021 | 163.91M | -30.39% |
| Oct 1, 2021 | 235.48M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Investor AB | 977.99B |
| Atlas Copco AB | 758.94B |
| AB Volvo | 574.74B |
| ASSA ABLOY AB | 392.66B |
| EQT AB | 376.22B |
| Skandinaviska Enskilda Banken AB | 374.88B |
| Sandvik AB | 361.76B |
| Swedbank AB | 345.14B |